Search any private company and open it for the full read — what they raised, how they compare to peers, and who's behind it.
| Company | Latest stage | Raised | Modeled value est. | |
|---|---|---|---|---|
| Moove Nigerian mobility startup Moove, which provides revenue-based vehicle financing to help individuals across Africa own their own vehicles, has raised a US$23 million Series A funding round to help it expand more quickly. | Series A | $63.2M | $617.4M | |
| Anthera Pharmaceuticals Inc · HAYWARD | Series A | $15.0M | $542.3M | |
| Bio-Dent, LTD. LLC · SIMI VALLEY | Series A | $15.0M | $542.3M | |
| Cynvec LLC · NEW YORK | Series A | $17.4M | $542.3M | |
| Dnanexus, Inc. · MOUNTAIN VIEW | Series A | $31.6M | $542.3M | |
| Foresight Biotherapeutics, Inc. · NEW YORK | Series A | $17.0M | $542.3M | |
| TechAccel, LLC · OVERLAND PARK | Series A | $15.0M | $542.3M | |
| TRACT Therapeutics, Inc. · CHICAGO | Series A | $15.0M | $542.3M | |
| Arrakis Therapeutics, Inc. · Waltham | Series A | $28.2M | $542.3M | |
| AuraSense Therapeutics, LLC · Skokie | Series A | $33.6M | $535.0M | |
| Biothera Holding Corp. · Eagan | Series A | $16.2M | $529.3M | |
| Complete Genomics Inc · MOUNTAIN VIEW | Series A | $14.5M | $523.8M | |
| Zyomyx Inc · Fremont | Series A | $15.2M | $514.1M | |
| Tobira Therapeutics, Inc. · MANALAPAN | Series A | $23.2M | $513.3M | |
| Limelight Bio, Inc. · PHILADELPHIA | Series A | $14.0M | $506.2M | |
| Champions Oncology, Inc. · HACKENSACK | Series A | $36.8M | $506.1M | |
| Neoprobe Corp · DUBLIN | Series A | $14.0M | $506.1M | |
| Thrasos Innovation Inc. · MONTREAL | Series A | $14.0M | $506.1M | |
| Trident Labs, Inc. · HOLLAND | Series A | $14.0M | $506.1M | |
| Akebia Therapeutics, Inc. · CINCINNATI | Series A | $25.9M | $504.1M | |
| Meissa Vaccines Inc · SOUTH SAN FRANCISCO | Series A | $15.2M | $503.1M | |
| Bitfxt Nigerian crypto-trading startup Bitfxt has raised a US$15 million Series A funding round for infrastructural expansion and the development of new products. | Series A | $15.0M | $502.5M | |
| Vibe Bioscience Ltd. · CALGARY | Series A | $13.9M | $501.1M | |
| Sano Intelligence, Inc. · SAN FRANCISCO | Series A | $13.8M | $500.2M | |
| Adimab, LLC · LEBANON | Series A | $13.8M | $499.5M | |
| Cryptzone Worldwide, Inc. · WALTHAM | Series A | $15.0M | $498.3M | |
| SRC Computers, LLC · COLORADO SPRINGS | Series A | $17.0M | $498.3M | |
| Overture Life, Inc. · NEW YORK | Series A | $13.6M | $491.7M | |
| Trovagene, Inc. · San Diego | Series A | $45.3M | $488.0M | |
| FogChain Corp. · SAN CARLOS | Series A | $14.7M | $486.8M | |
| Taiga Biotechnologies, Inc. · AURORA | Series A | $37.9M | $485.3M | |
| Equinox, Inc. · NEWPORT BEACH | Series A | $34.7M | $485.2M | |
| BioTrove, Inc. · WOBURN | Series A | $13.3M | $481.3M | |
| Aruna Biomedical Inc · ATHENS | Series A | $22.4M | $480.5M | |
| Vibe Bioscience Corp · CALGARY | Series A | $13.7M | $476.8M | |
| Merganser Biotech, Inc. · NEWTOWN SQUARE | Series A | $21.1M | $473.5M | |
| Progenics Pharmaceuticals Inc · TARRYTOWN | Series A | $12.9M | $467.2M | |
| Aliva Biopharmaceuticals, LLC · PASADENA | Series A | $12.9M | $465.3M | |
| ConteXtream Inc · Santa Clara | Series A | $14.0M | $465.1M | |
| Arbutus Biopharma Corp · Warminster | Series A | $15.0M | $464.6M | |
| Honest Globe Inc. · SANTA ANA | Series A | $15.0M | $464.6M | |
| Rvc 360, Llc · RUSKIN | Series A | $15.0M | $464.6M | |
| Satori Pharmaceuticals Inc · CAMBRIDGE | Series A | $22.3M | $464.6M | |
| Sinocom Pharmaceutical, Inc. · CENTRAL | Series A | $15.0M | $464.6M | |
| Sterrx, Llc · PLATTSBURGH | Series A | $18.0M | $464.6M | |
| Vitae Pharmaceuticals, Inc · FORT WASHINGTON | Series A | $15.0M | $464.6M | |
| Xynomic Pharmaceuticals Holdings, Inc. · SHANGHAI | Series A | $15.0M | $464.6M | |
| Ribometrix, Inc. · GREENVILLE | Series A | $18.5M | $464.6M | |
| TAI Diagnostics, Inc. · WAUWATOSA | Series A | $21.1M | $463.8M | |
| Occulo Holdings LLC · LEBANON | Series A | $12.8M | $462.7M | |
| Neuraltus Pharmaceuticals, Inc. · Palo Alto | Series A | $40.6M | $462.7M | |
| Adarza BioSystems, Inc. · ST. LOUIS | Series A | $31.5M | $461.9M | |
| Molecular Biometrics Inc · NORWOOD | Series A | $25.3M | $461.1M | |
| SiteOne Therapeutics, Inc. · Bozeman | Series A | $16.1M | $460.3M | |
| Predicine Holdings Ltd · HAYWARD | Series A | $26.2M | $458.6M | |
| Agilis Biotherapeutics, Inc. · CAMBRIDGE | Series A | $25.7M | $458.0M | |
| Bastille Networks, Inc. · ATLANTA | Series A | $13.8M | $457.6M | |
| Symbolic IO Corp · EDISON | Series A | $16.6M | $456.7M | |
| TARA Intelligence Inc. · SAN JOSE | Series A | $12.6M | $455.2M | |
| Labrys Biologics, Inc. · SAN FRANCISCO | Series A | $14.6M | $451.8M | |
| BEW Global, Inc. · GREENWOOD VILLAGE | Series A | $13.6M | $451.5M | |
| Elevation Pharmaceuticals Inc · SAN DIEGO | Series A | $27.4M | $448.3M | |
| Mnemosyne Pharmaceuticals Inc · PROVIDENCE | Series A | $24.0M | $445.8M | |
| CAMBRIDGE EPIGENETIX Ltd · Cambridge | Series A | $12.3M | $444.4M | |
| IntSights Cyber Intelligence Ltd. · HERZELIYA | Series A | $14.0M | $441.1M | |
| GeneWeave Biosciences, Inc. · LOS GATOS | Series A | $36.3M | $441.0M | |
| Advanced Bio Development, Inc. · ENGLEWOOD CLIFFS | Series A | $28.2M | $435.7M | |
| Xnor.Ai, Inc. · SEATTLE | Series A | $14.6M | $435.3M | |
| Comet Therapeutics, Inc. · CAMBRIDGE | Series A | $14.1M | $435.3M | |
| Generian Pharmaceuticals, Inc. · PITTSBURGH | Series A | $13.0M | $435.2M | |
| Macrogenics Inc · Rockville | Series A | $12.0M | $434.4M | |
| QUATRX PHARMACEUTICALS Co · ANN ARBOR | Series A | $14.0M | $434.4M | |
| Bioimagene Inc · SUNNYVALE | Series A | $12.0M | $433.8M | |
| Genten Therapeutics, Inc. · SAN FRANCISCO | Series A | $12.0M | $433.8M | |
| LTC BioSciences, Inc · GAINESVILLE | Series A | $12.0M | $433.8M | |
| Neurologica Corp · DANVERS | Series A | $17.0M | $433.8M | |
| Farapulse, Inc. · MENLO PARK | Series A | $36.3M | $433.8M | |
| Telsar Pharma, Inc. · BRIDGEWATER | Series A | $14.0M | $433.7M | |
| Aquinox Pharmaceuticals (Usa) Inc · RICHMOND | Series A | $30.6M | $433.6M | |
| Acetylon Pharmaceuticals, Inc. · BOSTON | Series A | $33.6M | $433.2M | |
| Qool Therapeutics, Inc. · MENLO PARK | Series A | $14.2M | $432.4M | |
| Neurovia, Inc. · SAN FRANCISCO | Series A | $13.9M | $432.1M | |
| Zoona SA fintech startup Zoona raises $15m from IFC, 4Di 0 By Tom Jackson on August 18, 2016 News , Southern Africa South African fintech company Zoona has raised US$15 million in a second round of financing led by the International Finance Corporation (IFC), which will help Zoona scale its operations to reach 10 markets and 30 million active consumers across Africa by 2020. The IFC, a branch of the World Bank, is joined by first round investors Accion, Omidyar Network and the Lundin Foundation in this new round for Zoona , which also includes investment from South African VC firm 4Di Capital. | Series A | $15.0M | $430.1M | |
| Bodymedia Inc · Pittsburgh | Series A | $20.1M | $429.9M | |
| Kano Computing Ltd · LONDON | Series A | $12.9M | $429.5M | |
| Romark Global Pharma, LLC · GUAYNABO | Series A | $13.8M | $428.5M | |
| Cequence Security, Inc. · SUNNYVALE | Series A | $21.6M | $428.0M | |
| Viewpoint Molecular Targeting, Inc. · CORALVILLE | Series A | $15.0M | $427.6M | |
| Alamab Therapeutics Inc. · PRINCETON | Series A | $11.8M | $426.6M | |
| Castle Intelligence, Inc. · SAN FRANCISCO | Series A | $11.7M | $423.4M | |
| Access Pharmaceuticals Inc · DALLAS | Series A | $39.2M | $423.2M | |
| NuVera Medical, Inc. · CAMPBELL | Series A | $11.7M | $423.0M | |
| Peloton Therapeutics, Inc. · DALLAS | Series A | $13.7M | $423.0M | |
| NeuroSigma, Inc. · Los Angeles | Series A | $13.8M | $421.3M | |
| Virident Systems Inc · Milpitas | Series A | $16.0M | $420.4M | |
| RadImmune Therapeutics, Inc. · TARRYTOWN | Series A | $13.6M | $420.0M | |
| Validity Sensors, Inc · San Jose | Series A | $12.6M | $417.9M | |
| Akoustis Technologies, Inc. · HUNTERSVILLE | Series A | $55.1M | $416.1M | |
| Celect, Inc. · BOSTON | Series A | $30.1M | $416.1M | |
| DiCentral Corp · HOUSTON | Series A | $15.0M | $416.1M |